Fig. (3) (A) Optical coherence tomography of the right eye before intravitreal bevacizumab (Avastin) treatment showed significant cystoid macular edema. Central subfield thickness was 646 µm. (B) After treatment with Avastin (x4), the edema was substantially improved and retinal thickness was reduced to 414 µm. (C) At 60 months, edema remained largely resolved with retinal thickness at 424 µm.